Tag: bone and mineral diagnostic testing market key players

  • Bone and Mineral Diagnostic Testing Market Growth Through 2030 Creates New Strategic Opportunities

    Bone and Mineral Diagnostic Testing Market Growth Through 2030 Creates New Strategic Opportunities

    Enhanced with market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports deliver more actionable and strategically valuable research.

    Bone and Mineral Diagnostic Testing Market Forecast Highlighting Growth From $1.2 Billion To $1.5 Billion

    The market for bone and mineral diagnostic testing has experienced robust expansion lately, projected to climb from $1.14 billion in 2025 to $1.2 billion by 2026, reflecting a compound annual growth rate of 5.4%. This past growth trajectory has been fueled by several factors, including a burgeoning elderly demographic, an escalating prevalence of osteoporosis, broader integration of bone mineral density assessments in clinical practice, enhanced accessibility to diagnostic imaging solutions, and the proliferation of laboratory testing services.

    The market for bone and mineral diagnostic testing is projected for substantial expansion in the upcoming years, anticipating a reach of $1.5 billion by 2030, fueled by a compound annual growth rate (CAGR) of 5.8%. This projected growth trajectory during the forecast period stems from heightened attention to proactive bone health strategies, a growing embrace of AI-integrated diagnostic technologies, the proliferation of diagnostic services offered in outpatient settings, an escalating need for early disease identification, and increased capital allocation towards sophisticated diagnostic platforms. Key developments anticipated within this timeframe encompass the wider implementation of cutting-edge bone density testing systems, a rise in the utilization of vitamin D and bone metabolism assays, the increasing incorporation of automated diagnostic equipment, an expansion of osteoporosis screening initiatives aimed at prevention, and a more pronounced emphasis on assessing early fracture risk.

    Download A Free Sample Report For Comprehensive Market Insights:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=10731&type=smp

    Bone and Mineral Diagnostic Testing Market Growth Drivers: What Factors Are Accelerating Expansion?

    The anticipated rise in bone ailments is poised to be a significant catalyst for the expansion of the bone and mineral diagnostic testing sector. These conditions affect skeletal integrity and resilience, leading to fragility and a heightened susceptibility to breaks, with manifestations including bone discomfort, mobility challenges, and a greater likelihood of fractures. Diagnostic procedures for bones and minerals, such as bone density assessments, play a crucial role in proactive bone health management by detecting diminished bone density before the onset of osteoporosis, estimating future fracture probabilities, and monitoring the effectiveness of current osteoporosis therapies. This escalating prevalence of bone disorders, combined with heightened public understanding and sophisticated technological progress, is projected to stimulate the bone and mineral diagnostic testing market’s advancement. As an illustration, the Institute for Health Transformation, an Australian research organization, projected in July 2025 that approximately 7.7 million Australians over the age of 50 will be affected by osteoporosis and osteopenia by the year 2033, marking a 23% surge from 2023 figures, underscoring the market’s growth trajectory.

    Bone and Mineral Diagnostic Testing Market Segment Analysis Highlighting Growth Areas

    The bone and mineral diagnostic testing market covered in this report is segmented –

    1) By Product: Assays Or Consumables, Instruments

    2) By Test Type: Enzyme-Linked Immunosorbent Assay (ELISA), Clinical Laboratory Improvement Amendments (CLIA), Other Test Types

    3) By Application: Vitamin D Testing, Bone Metabolism

    Subsegments:

    1) By Assays Or Consumables: Bone Turnover Markers Assays, Vitamin D Assays, Calcium And Phosphate Assays, Sample Collection Kits, Reagents And Standards

    2) By Instruments: Bone Densitometers, X-Ray Machines, Ultrasound Devices

    Bone and Mineral Diagnostic Testing Market Trends: What Is Shaping Future Industry Growth?

    In the bone and mineral diagnostic testing sector, prominent entities are actively pursuing novel offerings, exemplified by the Vitamin D Test, to enhance their market standing. This specific diagnostic procedure involves a blood analysis designed to quantify the concentration of vitamin D circulating within the bloodstream. Vitamin D serves as an indispensable nutrient, critically contributing to skeletal integrity, bolstering immune defenses, and governing a spectrum of bodily functions. Illustrating this trend, Hurdle, a Chronomics Inc. subsidiary, revealed in February 2023 the widespread accessibility of its Vitamin D Test. The assay quantifies 25-hydroxyvitamin D, a key biomarker reflecting the body’s vitamin D status, and its role in calcium metabolism and general well-being is well-established. This diagnostic tool is accessible via a network of healthcare providers, such as Quest Diagnostics, and can be performed either through traditional in-clinic sample collection or convenient at-home testing kits.

    Bone and Mineral Diagnostic Testing Market Leading Companies: Who Holds Significant Market Presence?

    Major companies operating in the bone and mineral diagnostic testing market are Abbott Laboratories, bioMérieux SA, DiaSorin S.p.A., QuidelOrtho Corporation, Siemens Healthineers AG, F. Hoffmann-La Roche AG, GE HealthCare Technologies Inc., Hologic Inc., Swissray International Inc., Osteosys Co. Ltd., Diagnostic Medical System SA, Epitope Diagnostics Inc., Beckman Coulter Inc., Bio Rad Laboratories Inc., Calbiotech Inc., Roche Diagnostics India Pvt. Ltd., Ortho-Clinical Diagnostics, Enzo Life Sciences Inc., Thermo Fisher Scientific Inc., Sysmex Corporation, EKF Diagnostics, Esaote SpA, Hitachi Ltd., Koninklijke Philips N.V., Mindray Medical International Limited, PerkinElmer Inc., Shimadzu Corporation, Toshiba Medical Systems Corporation, Beammed Ltd., Medonica Co. Ltd.

    Access The Complete Bone and Mineral Diagnostic Testing Market Report:

    https://www.thebusinessresearchcompany.com/report/bone-and-mineral-diagnostic-testing-global-market-report

    Bone and Mineral Diagnostic Testing Market Global Footprint: Which Region Holds Market Leadership?

    North Americawas the largest region in the bone and mineral diagnostic testing market in 2025. The regions covered in the bone and mineral diagnostic testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas: +1 310-496-7795

    Asia: +44 7882 955267 & +91 8897263534

    Europe: +44 7882 955267

    Email us at: marketing@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • Increasing Adoption Of Rising Incidence Of Bone-Related Diseases To Drive Growth In The Bone and Mineral Diagnostic Testing Market Is Influencing The Bone and Mineral Diagnostic Testing Market

    Increasing Adoption Of Rising Incidence Of Bone-Related Diseases To Drive Growth In The Bone and Mineral Diagnostic Testing Market Is Influencing The Bone and Mineral Diagnostic Testing Market

    The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

    What Market Value Trend Is Expected For The Bone and Mineral Diagnostic Testing Market From 2026 To 2030?

    The bone cancer treatment market has shown significant expansion in recent years. It is anticipated to grow from $1.37 billion in 2025 to $1.45 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 5.6%. This historical growth can be linked to several factors, such as the increasing incidence of bone-related cancers, the expansion of oncology treatment centers, the availability of chemotherapy and radiation therapies, improved cancer diagnostic capabilities, and growing clinical research activity.

    The bone cancer treatment market is projected to experience robust expansion in the coming years. This market is anticipated to reach $1.83 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 6.1%. Several factors are expected to drive this growth during the forecast period, including heightened investments in targeted therapies and immunotherapies, a greater embrace of personalized cancer treatment approaches, the development of sophisticated surgical oncology methods, an increased emphasis on research into rare cancers, and improved availability of specialized oncology services. Key trends anticipated for the forecast period involve a wider uptake of targeted bone cancer therapies, an increase in multimodal treatment strategies, the broader incorporation of precision oncology solutions, advancements in radiation and surgical techniques, and a sharpened focus on early detection coupled with individualized patient care.

    Download A Free Sample Report For Comprehensive Market Insights:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=10731&type=smp

    What Primary Factors Are Fueling The Expansion Of The Bone and Mineral Diagnostic Testing Market?

    The rising incidence of bone cancer is anticipated to propel the expansion of the bone cancer treatment market. Bone cancer refers to malignant tumors that develop within bone tissue, resulting from the uncontrolled division and growth of bone cells, which form a mass or tumor. Treatments for this condition are formulated to provide patients with various benefits, including surgery, limb preservation, pain alleviation, enhanced quality of life, and effective tumor management. For example, in February 2023, reports from the American Society of Clinical Oncology (ASCO), a US-based professional organization for physicians, projected that approximately 3,970 new cases of primary bone sarcoma (comprising 2,160 men and 1,810 women) would be diagnosed in the US in 2023, an increase from 400 cases in 201 among individuals aged 15 to 19. Therefore, the growing prevalence of bone cancer is a significant factor driving the bone cancer treatment market.

    What Key Segment Areas Are Included In The Bone and Mineral Diagnostic Testing Market Assessment?

    The bone and mineral diagnostic testing market covered in this report is segmented –

    1) By Product: Assays Or Consumables, Instruments

    2) By Test Type: Enzyme-Linked Immunosorbent Assay (ELISA), Clinical Laboratory Improvement Amendments (CLIA), Other Test Types

    3) By Application: Vitamin D Testing, Bone Metabolism

    Subsegments:

    1) By Assays Or Consumables: Bone Turnover Markers Assays, Vitamin D Assays, Calcium And Phosphate Assays, Sample Collection Kits, Reagents And Standards

    2) By Instruments: Bone Densitometers, X-Ray Machines, Ultrasound Devices

    Which Trends Are Influencing The Expansion Of The Bone and Mineral Diagnostic Testing Market?

    Leading companies operating in the bone cancer treatment market are concentrating on introducing next-generation drugs, including prescription medications, to gain a competitive advantage. A prescription medicine is a pharmaceutical drug that can only be legally obtained through a written order from a qualified healthcare professional, such as a doctor or dentist. As an illustration, in September 2023, GSK PLC, a UK-based pharmaceutical and biotechnology firm, launched Ojjaara (Momelotinib). Ojjaara (Momelotinib) is a prescription medicine utilized to treat adults suffering from certain types of myelofibrosis (MF), a rare form of bone marrow cancer that disrupts the body’s normal production of blood cells. This provides a new and effective treatment option for patients experiencing bone cancer and anemia.

    Who Are The Leading Firms Participating In The Bone and Mineral Diagnostic Testing Market?

    Major companies operating in the bone and mineral diagnostic testing market are Abbott Laboratories, bioMérieux SA, DiaSorin S.p.A., QuidelOrtho Corporation, Siemens Healthineers AG, F. Hoffmann-La Roche AG, GE HealthCare Technologies Inc., Hologic Inc., Swissray International Inc., Osteosys Co. Ltd., Diagnostic Medical System SA, Epitope Diagnostics Inc., Beckman Coulter Inc., Bio Rad Laboratories Inc., Calbiotech Inc., Roche Diagnostics India Pvt. Ltd., Ortho-Clinical Diagnostics, Enzo Life Sciences Inc., Thermo Fisher Scientific Inc., Sysmex Corporation, EKF Diagnostics, Esaote SpA, Hitachi Ltd., Koninklijke Philips N.V., Mindray Medical International Limited, PerkinElmer Inc., Shimadzu Corporation, Toshiba Medical Systems Corporation, Beammed Ltd., Medonica Co. Ltd.

    Access The Complete Bone and Mineral Diagnostic Testing Market Report:

    https://www.thebusinessresearchcompany.com/report/bone-and-mineral-diagnostic-testing-global-market-report

    Which Region Commands The Largest Share Of The Bone and Mineral Diagnostic Testing Market?

    North America was the largest region in the bone and mineral diagnostic testing market in 2025. The regions covered in the bone and mineral diagnostic testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Access Bone and Mineral Diagnostic Testing Market Report for Deeper Competitive Insights

    https://www.thebusinessresearchcompany.com/customise?id=10731&type=smp

    Browse Through More Reports Similar to the Global Bone and Mineral Diagnostic Testing Market 2026, By The Business Research Company

    Mineral And Bone Disorder Treatment Global Market Report 2026

    https://www.thebusinessresearchcompany.com/report/mineral-and-bone-disorder-treatment-global-market-report

    Bone Densitometer Market 2026

    https://www.thebusinessresearchcompany.com/report/bone-densitometer-market

    Osteoporosis Drugs Global Market Report 2026

    https://www.thebusinessresearchcompany.com/report/osteoporosis-drugs-global-market-report

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas: +1 310-496-7795

    Asia: +44 7882 955267 & +91 8897263534

    Europe: +44 7882 955267

    Email us at: marketing@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • Bone and mineral diagnostic testing market forecast with demand insights

    Bone and mineral diagnostic testing market forecast with demand insights

    The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

    What Changes In Market Value Are Expected For The Bone and Mineral Diagnostic Testing Market Over The 2026–2030 Period?

    The bone and mineral diagnostic testing market has demonstrated robust expansion over recent years. This market is anticipated to increase from $1.14 billion in 2025 to $1.2 billion in 2026, achieving a compound annual growth rate (CAGR) of 5.4%. Key drivers for this historical growth include an expanding aging population, a rise in osteoporosis cases, increased clinical acceptance of bone mineral density testing, the widespread availability of diagnostic imaging technologies, and the ongoing development of laboratory testing services.

    The market for bone and mineral diagnostic testing is projected to experience robust expansion over the coming years. It is anticipated to reach $1.5 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 5.8%. This growth during the forecast period can be attributed to an intensified focus on proactive bone health management, the increasing embrace of AI-assisted diagnostic instruments, the broadening of outpatient diagnostic offerings, a heightened need for early disease identification, and increased capital directed towards sophisticated diagnostic platforms. Significant trends anticipated in this period encompass the greater uptake of cutting-edge bone density testing systems, a surge in the utilization of vitamin D and bone metabolism assays, the increasing incorporation of automated diagnostic devices, the expansion of proactive osteoporosis screening initiatives, and a more pronounced emphasis on assessing early fracture risk.

    Access Your Free Sample Report For In-Depth Market Analysis:

    https://www.thebusinessresearchcompany.com/report/bone-and-mineral-diagnostic-testing-global-market-report

    What Key Drivers Are Fueling The Growth Of The Bone and Mineral Diagnostic Testing Market?

    The rising occurrence of bone-related diseases is projected to drive expansion in the bone and mineral diagnostic testing market going forward. These conditions are ailments that modify the strength or flexibility of bones, making them weaker and more susceptible to fractures, and can lead to symptoms such as bone pain, difficulty with movement, and a heightened risk of fractures. Bone and mineral diagnostic tests, including bone density tests, play a role in preventing bone diseases by detecting low bone density before osteoporosis develops, anticipating the risk of future fractures, and monitoring the effectiveness of ongoing osteoporosis treatment. The increasing incidence of bone-related diseases, along with rising awareness and technological progress, is expected to fuel the growth of the bone and mineral diagnostic testing market. For instance, in July 2025, the Institute for Health Transformation, an Australia-based nonprofit research institute, reported that by 2033, 7.7 million Australians aged 50 years and older are predicted to have osteoporosis and osteopenia, representing a 23% increase from 2023. Consequently, an increase in the incidence of bone-related diseases will propel the bone and mineral diagnostic testing market.

    How Is The Bone and Mineral Diagnostic Testing Market Broken Down By Segment Categories?

    The bone and mineral diagnostic testing market covered in this report is segmented –

    1) By Product: Assays Or Consumables, Instruments

    2) By Test Type: Enzyme-Linked Immunosorbent Assay (ELISA), Clinical Laboratory Improvement Amendments (CLIA), Other Test Types

    3) By Application: Vitamin D Testing, Bone Metabolism

    Subsegments:

    1) By Assays Or Consumables: Bone Turnover Markers Assays, Vitamin D Assays, Calcium And Phosphate Assays, Sample Collection Kits, Reagents And Standards

    2) By Instruments: Bone Densitometers, X-Ray Machines, Ultrasound Devices

    What Trends Are Influencing The Bone and Mineral Diagnostic Testing Market?

    Major companies within the bone and mineral diagnostic testing market are focusing on innovative solutions like the Vitamin D Test to strengthen their market position. A Vitamin D test is a blood analysis designed to measure the concentration of vitamin D in an individual’s blood. This crucial nutrient plays a vital role in maintaining bone health, supporting the immune system, and regulating various other physiological processes. For example, in February 2023, Hurdle, a brand under Chronomics Inc., announced the general availability of their Vitamin D Test. This particular test quantifies the amount of 25-hydroxyvitamin D, which acts as an indicator for the body’s overall Vitamin D level. This compound is essential for regulating calcium and contributing to overall health. The test is offered through several providers, including Quest Diagnostics, and can be completed via in-person sample collection or by using at-home test kits.

    Which Players Are Present In The Bone and Mineral Diagnostic Testing Market Space?

    Major companies operating in the bone and mineral diagnostic testing market are Abbott Laboratories, bioMérieux SA, DiaSorin S.p.A., QuidelOrtho Corporation, Siemens Healthineers AG, F. Hoffmann-La Roche AG, GE HealthCare Technologies Inc., Hologic Inc., Swissray International Inc., Osteosys Co. Ltd., Diagnostic Medical System SA, Epitope Diagnostics Inc., Beckman Coulter Inc., Bio Rad Laboratories Inc., Calbiotech Inc., Roche Diagnostics India Pvt. Ltd., Ortho-Clinical Diagnostics, Enzo Life Sciences Inc., Thermo Fisher Scientific Inc., Sysmex Corporation, EKF Diagnostics, Esaote SpA, Hitachi Ltd., Koninklijke Philips N.V., Mindray Medical International Limited, PerkinElmer Inc., Shimadzu Corporation, Toshiba Medical Systems Corporation, Beammed Ltd., Medonica Co. Ltd.

    Get The Full Bone and Mineral Diagnostic Testing Market Report:

    https://www.thebusinessresearchcompany.com/report/bone-and-mineral-diagnostic-testing-global-market-report

    Which Region Is The Top Contributor To The Bone and Mineral Diagnostic Testing Market By Share?

    North America was the largest region in the bone and mineral diagnostic testing market in 2025. The regions covered in the bone and mineral diagnostic testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Request A Customized Bone and Mineral Diagnostic Testing Market Report For Competitive Insights:

    https://www.thebusinessresearchcompany.com/report/bone-and-mineral-diagnostic-testing-global-market-report

    Browse Through More Reports Similar to the Global Bone and Mineral Diagnostic Testing Market 2026, By The Business Research Company

    Osteoporosis Drugs Market Report 2026

    https://www.thebusinessresearchcompany.com/report/osteoporosis-drugs-global-market-report

    Mineral And Bone Disorder Treatment Market Report 2026

    https://www.thebusinessresearchcompany.com/report/mineral-and-bone-disorder-treatment-global-market-report

    Bone Densitometer Market 2026

    https://www.thebusinessresearchcompany.com/report/bone-densitometer-market

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 310-496-7795

    Asia +44 7882 955267 & +91 8897263534

    Europe +44 7882 955267

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • Bone and Mineral Diagnostic Testing Market Revenue Growth Expected to Reach $1.5 Billion by 2030 with 5.8% CAGR

    Bone and Mineral Diagnostic Testing Market Revenue Growth Expected to Reach $1.5 Billion by 2030 with 5.8% CAGR

    The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

    What Market Size Expansion Is Predicted For The Bone and Mineral Diagnostic Testing Market Between 2026 And 2030?

    The bone and mineral diagnostic testing market has experienced robust expansion in recent years. Projections indicate its size will expand from $1.14 billion in 2025 to $1.2 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 5.4%. Historically, this expansion has been driven by factors such as an increasing aging population, a rising incidence of osteoporosis, the wider clinical adoption of bone mineral density testing, the availability of diagnostic imaging technologies, and the expansion of laboratory testing services.

    The bone and mineral diagnostic testing market is projected to experience substantial expansion in the coming years. This market is anticipated to reach $1.5 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 5.8%. The expansion during this forecast period stems from several factors, including a heightened emphasis on preventive bone health management, the increasing embrace of AI-assisted diagnostic tools, the broadening of outpatient diagnostic services, a rising need for early disease identification, and greater investments in sophisticated diagnostic platforms. Key trends throughout the forecast period encompass a wider uptake of advanced bone density testing systems, an increase in the utilization of vitamin D and bone metabolism assays, the progressive integration of automated diagnostic instruments, the broadening of preventive osteoporosis screening, and an intensified focus on assessing early fracture risk.

    Download the Free Sample Report to Explore Key Market Insights:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=10731&type=smp

    What Key Drivers Are Influencing The Growth Of The Bone and Mineral Diagnostic Testing Market?

    The projected increase in the occurrence of bone-related diseases is anticipated to accelerate the expansion of the bone and mineral diagnostic testing market in the future. These conditions are ailments that modify the strength or flexibility of bones, making them more fragile and prone to fractures, often causing symptoms such as bone pain, difficulty with movement, and a greater susceptibility to fractures. Bone and mineral diagnostic tests, like bone density tests, are instrumental in preventing bone diseases by identifying low bone density before osteoporosis develops, predicting the likelihood of future fractures, and monitoring the effectiveness of ongoing osteoporosis treatment. The escalating frequency of bone-related diseases, along with growing public awareness and technological progress, is expected to stimulate the growth of the bone and mineral diagnostic testing market. For example, in July 2025, the Institute for Health Transformation, an Australia-based nonprofit research institute, published findings indicating that by 2033, 7.7 million Australians aged 50 years and older are predicted to have osteoporosis and osteopenia, representing an increase of 23% from 2023. Thus, an uptick in the incidence of bone-related diseases will propel the bone and mineral diagnostic testing market.

    Which Market Segments Are Examined In The Bone and Mineral Diagnostic Testing Market Study?

    The bone and mineral diagnostic testing market covered in this report is segmented –

    1) By Product: Assays Or Consumables, Instruments

    2) By Test Type: Enzyme-Linked Immunosorbent Assay (ELISA), Clinical Laboratory Improvement Amendments (CLIA), Other Test Types

    3) By Application: Vitamin D Testing, Bone Metabolism

    Subsegments:

    1) By Assays Or Consumables: Bone Turnover Markers Assays, Vitamin D Assays, Calcium And Phosphate Assays, Sample Collection Kits, Reagents And Standards

    2) By Instruments: Bone Densitometers, X-Ray Machines, Ultrasound Devices

    Which Market Trends Are Creating New Opportunities In The Bone and Mineral Diagnostic Testing Market?

    Major companies operating in the bone and mineral diagnostic testing market are increasingly focusing on innovative solutions like the Vitamin D Test to solidify their market presence. A Vitamin D test is a type of blood examination designed to ascertain the concentration of vitamin D in an individual’s blood. This crucial nutrient plays a significant role in maintaining bone health, supporting the immune system, and regulating various other physiological functions. As an illustration, in February 2023, Hurdle, a brand under Chronomics Inc., declared the widespread availability of their Vitamin D Test. This test specifically measures the amount of 25-hydroxyvitamin D, which serves as an indicator for the body’s vitamin D level and contributes to calcium regulation and overall health. The test is accessible via diverse providers, including Quest Diagnostics, and can be performed through either in-person sample collection or at-home test kits.

    Who Are The Primary Competitors In The Bone and Mineral Diagnostic Testing Market?

    Major companies operating in the bone and mineral diagnostic testing market are Abbott Laboratories, bioMérieux SA, DiaSorin S.p.A., QuidelOrtho Corporation, Siemens Healthineers AG, F. Hoffmann-La Roche AG, GE HealthCare Technologies Inc., Hologic Inc., Swissray International Inc., Osteosys Co. Ltd., Diagnostic Medical System SA, Epitope Diagnostics Inc., Beckman Coulter Inc., Bio Rad Laboratories Inc., Calbiotech Inc., Roche Diagnostics India Pvt. Ltd., Ortho-Clinical Diagnostics, Enzo Life Sciences Inc., Thermo Fisher Scientific Inc., Sysmex Corporation, EKF Diagnostics, Esaote SpA, Hitachi Ltd., Koninklijke Philips N.V., Mindray Medical International Limited, PerkinElmer Inc., Shimadzu Corporation, Toshiba Medical Systems Corporation, Beammed Ltd., Medonica Co. Ltd.

    Read the full bone and mineral diagnostic testing market report here:

    https://www.thebusinessresearchcompany.com/report/bone-and-mineral-diagnostic-testing-global-market-report

    Which Region Is Expected To Register The Fastest Growth In The Bone and Mineral Diagnostic Testing Market?

    North America was the largest region in the bone and mineral diagnostic testing market in 2025. The regions covered in the bone and mineral diagnostic testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Request A Tailored Bone and Mineral Diagnostic Testing Market Research Report For Competitive Advantage:

    https://www.thebusinessresearchcompany.com/customise?id=10731&type=smp

    Browse Through More Reports Similar to the Global Bone and Mineral Diagnostic Testing Market 2026, By The Business Research Company

    Mineral And Bone Disorder Treatment Global Market Report

    https://www.thebusinessresearchcompany.com/report/mineral-and-bone-disorder-treatment-global-market-report

    Bone Densitometer Market

    https://www.thebusinessresearchcompany.com/report/bone-densitometer-market

    Osteoporosis Drugs Global Market Report

    https://www.thebusinessresearchcompany.com/report/osteoporosis-drugs-global-market-report

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 310-496-7795

    Asia +44 7882 955267 & +91 8897263534

    Europe +44 7882 955267

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • Bone and Mineral Diagnostic Testing Market Forecast 2026–2035: Data Trends and Industry Insights

    Bone and Mineral Diagnostic Testing Market Forecast 2026–2035: Data Trends and Industry Insights

    Uncover key drivers, emerging technologies, and competitive movements shaping the bone and mineral diagnostic testing market from 2026–2035 with trusted insights from The Business Research Company

    How much is the Bone and Mineral Diagnostic Testing Market valued at in 2026, and what valuation is forecast for 2030?

    The bone and mineral diagnostic testing market has experienced robust growth in recent years. This market is projected to expand from $1.14 billion in 2025 to $1.2 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 5.4%. Historically, the growth in this sector has been driven by an increasing aging population, a rising incidence of osteoporosis, broader clinical adoption of bone mineral density testing, the availability of diagnostic imaging technologies, and an expansion of laboratory testing services.

    The bone and mineral diagnostic testing market is projected to experience robust expansion in the coming years. This market is anticipated to reach a valuation of $1.5 billion by 2030, driven by a compound annual growth rate (CAGR) of 5.8%. This predicted growth during the forecast timeframe is primarily due to a heightened emphasis on preventive bone health management, the increasing use of AI-assisted diagnostic tools, the broadening of outpatient diagnostic services, a surging need for early disease identification, and greater capital expenditure in sophisticated diagnostic platforms. Key trends shaping this period encompass the wider deployment of advanced bone density testing systems, an uptick in the utilization of vitamin D and bone metabolism assays, the progressive incorporation of automated diagnostic instruments, the broadening of preventive osteoporosis screening initiatives, and a sharpened focus on early assessment of fracture risk.

    Access Your Free Sample Report for In-Depth Market Insights:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=10731&type=smp

    What Drivers Are Influencing The Growth Of The Bone and Mineral Diagnostic Testing Market?

    The escalating occurrence of bone-related conditions is projected to drive the expansion of the bone and mineral diagnostic testing market moving forward. These diseases are ailments that compromise the strength or flexibility of bones, rendering them more fragile and susceptible to fractures, and can present symptoms such as bone discomfort, difficulty with movement, and a higher risk of bone fractures. Bone and mineral diagnostic tests, including bone density tests, play a crucial role in preventing bone diseases by identifying low bone density before osteoporosis progresses, forecasting the likelihood of future fractures, and monitoring the effectiveness of ongoing osteoporosis treatment. The increasing prevalence of bone-related diseases, coupled with growing awareness and technological advancements, is expected to fuel the growth of the bone and mineral diagnostic testing market. For instance, in July 2025, the Institute for Health Transformation, an Australia-based nonprofit research institute, announced that by 2033, an estimated 7.7 million Australians aged 50 years and older are predicted to have osteoporosis and osteopenia, marking a 23% increase from 2023. Consequently, a rise in the incidence of bone-related diseases will propel the bone and mineral diagnostic testing market.

    What Segments Are Included Within The Bone and Mineral Diagnostic Testing Market?

    The bone and mineral diagnostic testing market covered in this report is segmented –

    1) By Product: Assays Or Consumables, Instruments

    2) By Test Type: Enzyme-Linked Immunosorbent Assay (ELISA), Clinical Laboratory Improvement Amendments (CLIA), Other Test Types

    3) By Application: Vitamin D Testing, Bone Metabolism

    Subsegments:

    1) By Assays Or Consumables: Bone Turnover Markers Assays, Vitamin D Assays, Calcium And Phosphate Assays, Sample Collection Kits, Reagents And Standards

    2) By Instruments: Bone Densitometers, X-Ray Machines, Ultrasound Devices

    What Trends Are Expected To Impact The Competitive Landscape Of The Bone and Mineral Diagnostic Testing Market?

    Leading firms in the bone and mineral diagnostic testing market are focusing on innovative solutions such as the Vitamin D Test to strengthen their market position. A Vitamin D test is a blood examination that quantifies the amount of vitamin D in an individual’s blood. Vitamin D is a vital nutrient, playing a crucial role in supporting bone health, bolstering the immune system, and regulating various other physiological functions. For instance, in February 2023, Hurdle, a brand under Chronomics Inc., announced the general availability of its Vitamin D Test. This test measures the level of 25-hydroxyvitamin D, which indicates the body’s vitamin D status. It is involved in regulating calcium and sustaining overall health. The test can be accessed through multiple providers, including Quest Diagnostics, and performed via in-person sample collection or with at-home test kits.

    Who Are The Core Companies Influencing Trends In The Bone and Mineral Diagnostic Testing Market?

    Major companies operating in the bone and mineral diagnostic testing market are Abbott Laboratories, bioMérieux SA, DiaSorin S.p.A., QuidelOrtho Corporation, Siemens Healthineers AG, F. Hoffmann-La Roche AG, GE HealthCare Technologies Inc., Hologic Inc., Swissray International Inc., Osteosys Co. Ltd., Diagnostic Medical System SA, Epitope Diagnostics Inc., Beckman Coulter Inc., Bio Rad Laboratories Inc., Calbiotech Inc., Roche Diagnostics India Pvt. Ltd., Ortho-Clinical Diagnostics, Enzo Life Sciences Inc., Thermo Fisher Scientific Inc., Sysmex Corporation, EKF Diagnostics, Esaote SpA, Hitachi Ltd., Koninklijke Philips N.V., Mindray Medical International Limited, PerkinElmer Inc., Shimadzu Corporation, Toshiba Medical Systems Corporation, Beammed Ltd., Medonica Co. Ltd.

    Access The Complete Report For Deeper Market Insights:

    https://www.thebusinessresearchcompany.com/report/bone-and-mineral-diagnostic-testing-global-market-report

    Which Regions Are Projected To Dominate The Bone and Mineral Diagnostic Testing Market In The Coming Years?

    North America was the largest region in the bone and mineral diagnostic testing market in 2025. The regions covered in the bone and mineral diagnostic testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Request Your Customized Bone and Mineral Diagnostic Testing Market Research Report for Competitive Advantage:

    https://www.thebusinessresearchcompany.com/customise?id=10731&type=smp

    Browse Through More Reports Similar to the Global Bone and Mineral Diagnostic Testing Market 2026, By The Business Research Company

    Osteoporosis Drugs Market Report 2026

    https://www.thebusinessresearchcompany.com/report/osteoporosis-drugs-global-market-report

    Mineral And Bone Disorder Treatment Market Report 2026

    https://www.thebusinessresearchcompany.com/report/mineral-and-bone-disorder-treatment-global-market-report

    Bone Densitometer Market 2026

    https://www.thebusinessresearchcompany.com/report/bone-densitometer-market

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 310-496-7795

    Asia +44 7882 955267 & +91 8897263534

    Europe +44 7882 955267

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • Bone and Mineral Diagnostic Testing Industry Forecast to Hit $1.41 Billion by 2029 With a Strong 5.6% CAGR

    Bone and Mineral Diagnostic Testing Industry Forecast to Hit $1.41 Billion by 2029 With a Strong 5.6% CAGR

    Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

    #What Are The Current (2025) And Forecast (2029) Sizes Of The Bone and Mineral Diagnostic Testing Market?

    The bone and mineral diagnostic testing market has seen consistent expansion in recent years. Its value is anticipated to increase from $1.09 billion in 2024 to $1.14 billion in 2025, progressing at a compound annual growth rate (CAGR) of 4.6%. The increase observed historically is linked to factors such as the needs of an aging population, the common occurrence of osteoporosis, various awareness and education programs, the clinical necessity for monitoring, and the assessment of fracture risk.

    The bone and mineral diagnostic testing market is anticipated to show significant expansion over the next few years. It is predicted to reach $1.41 billion by 2029, achieving a compound annual growth rate (CAGR) of 5.6%. This projected growth is attributed to progress in diagnostic technologies, a rising occurrence of metabolic bone diseases, an increasing emphasis on preventive healthcare, and the integration of personalized medicine approaches. Prominent trends expected during this forecast period include the incorporation of biochemical markers, the use of telemedicine and remote monitoring, an increase in home-based testing kits, collaborative efforts for research and innovation, and a focus on comprehensive diagnostic panels.

    Unlock Your Free Sample Report for Exclusive Market Data:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=10731&type=smp

    Which Drivers Are Supporting Growth Of The Bone and Mineral Diagnostic Testing Market?

    The bone and mineral diagnostic testing market is projected to grow as the incidence of bone-related diseases increases. These conditions impair bone strength and flexibility, rendering them weaker and more susceptible to fractures, potentially causing bone pain, movement difficulties, and a heightened risk of breaks. Diagnostic tools for bone and minerals, such as bone density tests, play a vital role in disease prevention by identifying low bone density before osteoporosis fully develops, estimating future fracture risks, and assessing the effectiveness of ongoing osteoporosis treatments. The expanding prevalence of bone-related diseases, combined with rising awareness and technological progress, is expected to drive market expansion. For example, in May 2022, The National Center for Biotechnology Information (NCBI), a US-based government organization, indicated that fractures are the primary complication of osteoporosis, with global hip fractures predicted to rise by 310% among men and 240% among women by 2050. Therefore, the increase in bone-related disease incidence will propel the bone and mineral diagnostic testing market.

    What Are The Major Segment Types Covered In The Bone and Mineral Diagnostic Testing Market?

    The bone and mineral diagnostic testingmarket covered in this report is segmented –

    1) By Product: Assays Or Consumables; Instruments

    2) By Test Type: Enzyme-Linked Immunosorbent Assay (ELISA); Clinical Laboratory Improvement Amendments (CLIA); Other Test Types

    3) By Application: Vitamin D Testing; Bone Metabolism

    Subsegments:

    1) By Assays Or Consumables: Bone Turnover Markers Assays; Vitamin D Assays; Calcium And Phosphate Assays; Sample Collection Kits; Reagents And Standards

    2) By Instruments: Bone Densitometers; X-Ray Machines; Ultrasound Devices; MRI Machines; Other Diagnostic Instruments

    Which Trends Are Impacting The Bone and Mineral Diagnostic Testing Market?

    A significant trend gaining traction in the bone and mineral diagnostic testing market is technological progress. Companies active in the bone and mineral diagnostic testing market are adopting new technologies to maintain their standing. For example, in May 2022, GE HealthCare Technologies Inc., a US-based medical technology company, created an innovative MRI technique employing novel pulse sequences such as zero echo time (ZTE) to visualize tendons, ligaments, calcium deposits, and cortical bone structures. This new development in MR bone imaging provides image contrast similar to computed tomography (CT) in 3D isotropic resolution, without subjecting the patient to ionizing radiation. It is currently utilized to gather morphological data regarding cortical bone structure in body parts such as the shoulder, hip, skull, foot/ankle, and spine. Its promise is particularly attractive when longitudinal CT scans are necessary, especially if low-dose CTs are not an option.

    Which Major Firms Are Strengthening Their Position In The Bone and Mineral Diagnostic Testing Industry?

    Major companies operating in the bone and mineral diagnostic testing market include Abbott Laboratories, bioMérieux SA, DiaSorin S.p.A., QuidelOrtho Corporation, Siemens Healthineers AG, F. Hoffmann-La Roche AG, GE HealthCare Technologies Inc., Hologic Inc., Beammed Ltd., Swissray International Inc., Osteosys Co. Ltd., Diagnostic Medical System SA, Medonica Co. Ltd., Epitope Diagnostics Inc., Alere Inc., Beckman Coulter Inc., Bio Rad Laboratories Inc., Calbiotech Inc., Roche Diagnostics India Pvt. Ltd., Ortho-Clinical Diagnostics, Enzo Life Sciences lnc., Medtronic plc, Thermo Fisher Scientific lnc., Sysmex Corporation, EKF Diagnostics, Bruker Corporation, Esaote SpA, Hitachi Ltd., Koninklijke Philips N.V., Mindray Medical International Limited, PerkinElmer Inc., Shimadzu Corporation, Toshiba Medical Systems Corporation, Waters Corporation, Danaher Corporation, Merck KGaA

    Download The Full Report For Exclusive Market Findings:

    https://www.thebusinessresearchcompany.com/report/bone-and-mineral-diagnostic-testing-global-market-report

    What Are The Regional Market Dynamics Impacting The Bone and Mineral Diagnostic Testing Industry?

    North America was the largest region in the bone and mineral diagnostic testing market in 2024. The regions covered in the bone and mineral diagnostic testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

    Request A Customized Version Of The Bone and Mineral Diagnostic Testing Market Report:

    https://www.thebusinessresearchcompany.com/customise?id=10731&type=smp

    Browse Through More Reports Similar to the Global Bone and Mineral Diagnostic Testing Market 2025, By The Business Research Company

    Prosthetic Heart Valve Devices And Equipment Global Market Report 2025

    https://www.thebusinessresearchcompany.com/report/prosthetic-heart-valve-devices-and-equipment-global-market-report

    Facial Tissues Global Market Report 2025

    https://www.thebusinessresearchcompany.com/report/facial-tissues-global-market-report

    Surgical Sealants And Adhesives Global Market Report 2025

    https://www.thebusinessresearchcompany.com/report/surgical-sealants-and-adhesives-global-market-report

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 310-496-7795

    Asia +44 7882 955267 & +91 8897263534

    Europe +44 7882 955267

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • Bone and Mineral Diagnostic TestingMarket Overview 2025–2034: CAGR Trends, Long-Term Growth Paths, and Business Implications

    Bone and Mineral Diagnostic TestingMarket Overview 2025–2034: CAGR Trends, Long-Term Growth Paths, and Business Implications

    Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

    What Are the Key Projections for the CAGR of the Bone and Mineral Diagnostic Testing Market Size From 2025 to 2034?

    In recent years, the market size for bone and mineral diagnostic testing has exhibited consistent growth. This market is predicted to expand from a valuation of $1.09 billion in 2024 to an estimated worth of $1.14 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 4.6%. This prior period of growth can be linked to factors such as the needs of an aging population, an increased occurrence of osteoporosis, heightened awareness and educational initiatives, a clinical requirement for monitoring, and an assessment of fracture risk.

    The size of the bone and mineral diagnostic testing market is projected to experience robust growth in the upcoming years. It is anticipated to reach $1.41 billion in 2029, with a compound annual growth rate (CAGR) of 5.6%. The growth predicted during this forecast period can be ascribed to improvements in diagnostic technologies, an upward trend in metabolic bone diseases, a rising emphasis on preventive healthcare, and the inclusion of personalized medicine methodologies. Key trends during the forecasted period include the incorporation of biochemical markers, advancements in telemedicine and remote monitoring, the spread of at-home testing kits, collaborative efforts in research and innovation, and a focus on wide-ranging diagnostic panels.

    Download a free sample to assess the report’s scope and structure:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=10731&type=smp

    What Are the Primary Drivers Supporting the Market Growth of the Bone and Mineral Diagnostic Testing Market?

    The escalation of bone-related health issues is projected to drive the growth of the bone and mineral diagnostic testing industry. These conditions, which compromise bone strength and resilience, elevate the risk of fractures and symptoms like bone pain, impaired mobility, and an increased rate of bone fractures. Preventative measures for these diseases, such as bone mineral diagnostic tests and bone density tests, can identify deficient bone density in its early stages, predict future fracture risks, and examine the effectiveness of current osteoporosis treatments. The rising prevalence of bone-related diseases, combined with heightened awareness and technological progress, is predicted to stimulate the growth of this industry. As an illustration, in May 2022, The National Center for Biotechnology Information (NCBI), a US government agency, projected a 310% surge in global hip fracture rates among men and a 240% jump among women due to osteoporosis by 2050. Consequently, the growing incidence of bone-related diseases underscores the significance of the bone and mineral diagnostic testing market.

    Which Primary Segments of the Bone and Mineral Diagnostic Testing Market Are Driving Growth and Industry Transformations?

    The bone and mineral diagnostic testingmarket covered in this report is segmented –

    1) By Product: Assays Or Consumables; Instruments

    2) By Test Type: Enzyme-Linked Immunosorbent Assay (ELISA); Clinical Laboratory Improvement Amendments (CLIA); Other Test Types

    3) By Application: Vitamin D Testing; Bone Metabolism

    Subsegments:

    1) By Assays Or Consumables: Bone Turnover Markers Assays; Vitamin D Assays; Calcium And Phosphate Assays; Sample Collection Kits; Reagents And Standards

    2) By Instruments: Bone Densitometers; X-Ray Machines; Ultrasound Devices; MRI Machines; Other Diagnostic Instruments

    Request customized data on this market:

    https://www.thebusinessresearchcompany.com/customise?id=10731&type=smp

    Which Regions Are Key Players in the Growth of the #What Are the Primary Drivers Supporting the Market Growth of the Bone and Mineral Diagnostic Testing Market?# Market?

    North America was the largest region in the bone and mineral diagnostic testing market in 2024. The regions covered in the bone and mineral diagnostic testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

    What Are the Most Significant Market Trends in the Bone and Mineral Diagnostic Testing Market?

    In the bone and mineral diagnostic testing market, technological innovation is an emerging and influential trend. To maintain their market dominance, companies within this field are incorporating the latest technologies. GE HealthCare Technologies Inc., an American medical technology firm, pioneered in May 2022, a new MRI technique that employs cutting-edge pulse sequences like zero echo time (ZTE). This reaches areas such as tendons, ligaments, calcium deposits, and cortical bone structures. This groundbreaking MR bone imaging technique offers CT-like image contrast in 3D isotropic resolution without exposing patients to any ionizing radiation. Presently, it’s used to gather morphological data on cortical bone structures in areas such as the shoulder, hip, skull, foot/ankle, and spine. This technique showcases promising potential, especially when sequential CT scans are needed, primarily if low-dose CTs are not available.

    View the full report here:

    https://www.thebusinessresearchcompany.com/report/bone-and-mineral-diagnostic-testing-global-market-report

    What Parameters Are Used to Define the Bone and Mineral Diagnostic Testing Market?

    A bone and mineral diagnostic test is a medical treatment that determines the quantity of calcium and other minerals in a section of bone. This test is used to detect bone loss and osteoporosis, monitor osteoporosis therapy, and assess the risk of fractures.

    Purchase the full report and get a swift delivery:

    https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=10731

    About The Business Research Company:

    With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 310-496-7795

    Europe +44 7882 955267

    Asia & Others +44 7882 955267 & +91 8897263534

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • Bone and Mineral Diagnostic Testing Industry Insights 2025 – Market Forecast for Executives and Planners

    Bone and Mineral Diagnostic Testing Industry Insights 2025 – Market Forecast for Executives and Planners

    Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

    How Has the Bone and Mineral Diagnostic Testing Market Size Changed, over the years?

    Over the past few years, there has been a steady increase in the size of the bone and mineral diagnostic testing market. The market, which was worth $1.09 billion in 2024, is projected to rise to $1.14 billion in 2025, with a compound annual growth rate (CAGR) of 4.9%. This growth during the previous period is linked to factors such as the needs of an aging population, the pervasiveness of osteoporosis, initiatives for awareness and education, the clinical requirement for monitoring, and evaluation of fracture risk.

    How Much Will the Bone and Mineral Diagnostic Testing Market Be Worth in 2029?

    The market size for bone and mineral diagnostic testing is predicted to experience significant growth in the upcoming years, expanding to “$1.42 billion in 2029 with a compound annual growth rate (CAGR) of 5.6%. The potential growth during this period can be associated with improved diagnostic technologies, a rising number of metabolic bone disorders, an increasing focus on preventative healthcare, and merging with personalized medicine methods. The primary trends projected during the forecast period concern the incorporation of biochemical markers, telemedicine and distant monitoring, the proliferation of at-home testing kits, partnerships for research and development, and a focus on extensive diagnostic panels.

    Download The Free Sample Report Here:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=10731&type=smp

    Which is the Largest Company in the Bone and Mineral Diagnostic Testing Market?

    Major companies operating in the bone and mineral diagnostic testing market include Abbott Laboratories, bioMérieux SA, DiaSorin S.p.A., QuidelOrtho Corporation, Siemens Healthineers AG, F. Hoffmann-La Roche AG, GE HealthCare Technologies Inc., Hologic Inc., Beammed Ltd., Swissray International Inc., Osteosys Co. Ltd., Diagnostic Medical System SA, Medonica Co. Ltd., Epitope Diagnostics Inc., Alere Inc., Beckman Coulter Inc., Bio Rad Laboratories Inc., Calbiotech Inc., Roche Diagnostics India Pvt. Ltd., Ortho-Clinical Diagnostics, Enzo Life Sciences lnc., Medtronic plc, Thermo Fisher Scientific lnc., Sysmex Corporation, EKF Diagnostics, Bruker Corporation, Esaote SpA, Hitachi Ltd., Koninklijke Philips N.V., Mindray Medical International Limited, PerkinElmer Inc., Shimadzu Corporation, Toshiba Medical Systems Corporation, Waters Corporation, Danaher Corporation, Merck KGaA

    What Are the Main Market Drivers in the Bone and Mineral Diagnostic Testing Industry?

    The escalation of bone-related disease prevalence is anticipated to stimulate the expansion of the bone and mineral diagnostic testing market. Bone-related ailments, which compromise the flexibility or strength of bones, rendering them more susceptible to fractures, manifest symptoms such as bone discomfort, impaired movement, and higher bone fracture likelihood. Bone and mineral diagnostic tests, such as bone density assessments, assist in forestalling these diseases by identifying low bone density before osteoporosis develops, predicting future fracture risks, and monitoring the effectiveness of ongoing osteoporosis treatments. The rising occurrence of bone-related diseases, along with heightened awareness and technology advancements, is projected to spur the growth of the bone and mineral diagnostic testing market. For instance, The National Center for Biotechnology Information (NCBI), a US-based government entity, reported in May 2022 that fractures are the main complication of osteoporosis, estimating a looming 310% surge in global hip fractures among men and a 240% increase in women by 2050. Hence, the surge in bone-related disease prevalence will fuel growth in the bone and mineral diagnostic testing market.

    Request For A Customized Report:

    https://www.thebusinessresearchcompany.com/customise?id=10731&type=smp

    How Is the Bone and Mineral Diagnostic Testing Market Segments Structured?

    The bone and mineral diagnostic testing market covered in this report is segmented –

    1) By Product: Assays Or Consumables, Instruments

    2) By Test Type: Enzyme-Linked Immunosorbent Assay (ELISA), Clinical Laboratory Improvement Amendments (CLIA), Other Test Types

    3) By Application: Vitamin D Testing, Bone Metabolism

    Subsegments:

    1) By Assays Or Consumables: Bone Turnover Markers Assays, Vitamin D Assays, Calcium And Phosphate Assays, Sample Collection Kits, Reagents And Standards

    2) By Instruments: Bone Densitometers, X-Ray Machines, Ultrasound Devices, MRI Machines, Other Diagnostic Instruments

    What Strategic Trends Are Transforming the Bone and Mineral Diagnostic Testing Market?

    The proliferation of new technologies is a significant trend emerging in the bone and mineral diagnostic testing market. To maintain their market standings, companies in the bone and mineral diagnostic testing sector are implementing cutting-edge technologies. In May 2022, GE HealthCare Technologies Inc., an American medical technology firm, introduced an innovative MRI method employing unique pulse sequences like zero echo time (ZTE) for visualizing tendons, ligaments, calcium accumulations, and cortical bone frameworks. This groundbreaking progress in MR bone imaging offers CT-like image contrast in 3D isotropic resolution, all the while sparing the patient from any ionizing radiation exposure. Currently, it is employed for procuring morphological data concerning cortical bone structure in anatomical regions such as the shoulder, hip, skull, foot/ankle, and spine. It carries particular allure in cases where successive CT scans are required, mainly when low-dose CTs are not accessible.

    Access The Full Report Here:

    https://www.thebusinessresearchcompany.com/report/bone-and-mineral-diagnostic-testing-global-market-report

    Which Global Regions Offer the Highest Growth in the Bone and Mineral Diagnostic Testing Market?

    North America was the largest region in the bone and mineral diagnostic testing market in 2024. The regions covered in the bone and mineral diagnostic testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

    Purchase The Full Report Today:

    https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=10731

    This Report Delivers Insight On:

    1. How big is the bone and mineral diagnostic testing market, and how is it changing globally?

    2. Who are the major companies in the bone and mineral diagnostic testing market, and how are they performing?

    3. What are the key opportunities and risks in the bone and mineral diagnostic testing market right now?

    4. Which products or customer segments are growing the most in the bone and mineral diagnostic testing market?

    5. What factors are helping or slowing down the growth of the bone and mineral diagnostic testing market?

    About The Business Research Company:

    With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 3156230293

    Asia +44 2071930708

    Europe +44 2071930708

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • Bone and Mineral Diagnostic Testing Market Overview 2025–2034: CAGR Trends, Long-Term Growth Paths, and Business Implications

    Bone and Mineral Diagnostic Testing Market Overview 2025–2034: CAGR Trends, Long-Term Growth Paths, and Business Implications

    Discover trends, market shifts, and competitive outlooks for the bone and mineral diagnostic testing industry through 2025-2034 with The Business Research Company’s reliable data and in-depth research

    What is the Projected CAGR for the Bone and Mineral Diagnostic Testing Market Size from 2025 to 2034?

    In the past few years, the bone and mineral diagnostic testing market has been experiencing steady growth. It is projected to escalate from $1.09 billion in 2024 to $1.14 billion in 2025, with a compound annual growth rate (CAGR) of 4.9%. Factors that contributed to growth during the historical period include increased demand due to an aging population, the widespread prevalence of osteoporosis, initiatives aimed at fostering awareness and education, the clinical necessity for monitoring, and the need for fracture risk assessment.

    The market size for diagnostic testing of bone and mineral is anticipated to witness robust expansion in the upcoming years, escalating to “$1.42 billion by 2029 with a compound annual growth rate (CAGR) of 5.6%. This surge in the projected period is credited to the progress in diagnostic technologies, the rising prevalence of metabolic bone ailments, an increased emphasis on preventive healthcare, and integration with personalized medicine methodologies. Noteworthy trends during the forecasted timeframe encompass the integration of biochemical markers, the growth of telemedicine and remote patient monitoring, the proliferation of home testing kits, partnerships for research and innovation, and the focus on extensive diagnostic panels.

    Download a free sample to assess the report’s scope and structure:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=10731&type=smp

    What Are the Primary Drivers Supporting the Market Growth of the Bone and Mineral Diagnostic Testing Market?

    The escalation of bone-related diseases is predicted to bolster the expansion of the bone and mineral diagnostic testing market. These are health conditions that compromise the resilience or flexibility of bones, making them susceptible to fractures, and can lead to complications such as bone pain, mobility difficulties, and a heightened possibility of bone fractures. Diagnostic tests for bone and mineral, such as bone density tests, play a pivotal role in thwarting bone diseases by spotting low bone density before the onset of osteoporosis, predicting the likelihood of future fractures, and gauging the effectiveness of current osteoporosis treatment measures. The surging instances of bone-related diseases, coupled with increased awareness and technological advances, are projected to stimulate the growth of the bone and mineral diagnostic testing market. For instance, in May 2022, The National Center for Biotechnology Information (NCBI), a US Government entity, reported that fractures are the main concern of osteoporosis, with forecasts indicating a 310% surge in worldwide hip fractures among men and a 240% surge among women by 2050. Therefore, the surge in the occurrence of bone-related diseases is set to influence the growth of the bone and mineral diagnostic testing market.

    Which Primary Segments of the Bone and Mineral Diagnostic Testing Market Are Driving Growth and Industry Transformations?

    The bone and mineral diagnostic testing market covered in this report is segmented –

    1) By Product: Assays Or Consumables, Instruments

    2) By Test Type: Enzyme-Linked Immunosorbent Assay (ELISA), Clinical Laboratory Improvement Amendments (CLIA), Other Test Types

    3) By Application: Vitamin D Testing, Bone Metabolism

    Subsegments:

    1) By Assays Or Consumables: Bone Turnover Markers Assays, Vitamin D Assays, Calcium And Phosphate Assays, Sample Collection Kits, Reagents And Standards

    2) By Instruments: Bone Densitometers, X-Ray Machines, Ultrasound Devices, MRI Machines, Other Diagnostic Instruments

    Request customized data on this market:

    https://www.thebusinessresearchcompany.com/customise?id=10731&type=smp

    Which Regions Are Key Players in the Growth of the #What Are the Primary Drivers Supporting the Market Growth of the Bone and Mineral Diagnostic Testing Market?# Market?

    North America was the largest region in the bone and mineral diagnostic testing market in 2024. The regions covered in the bone and mineral diagnostic testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

    What Are the Most Significant Market Trends in the Bone and Mineral Diagnostic Testing Market?

    Advancements in technology are emerging as a major trend in the bone and mineral diagnostic testing market sector. Firms present in this market are turning to innovative technologies to maintain their standing. For instance, in May 2022, GE HealthCare Technologies Inc., an American med-tech business, created an ingenious MRI method involving novel pulse sequences such as zero echo time (ZTE). This enhancement in MR bone imaging offers a comparable image contrast to computed tomography (CT) in 3D isotropic resolution, all while ensuring the patient is not exposed to ionizing radiation. At present, this developed technique is being utilized to gain morphological data related to the cortical bone structure in various anatomical locations, like the shoulder, hip, skull, foot/ankle, and spine. It showcases great potential particularly when there is a need for longitudinal CTs, especially when low-dose CTs are not available.

    View the full report here:

    https://www.thebusinessresearchcompany.com/report/bone-and-mineral-diagnostic-testing-global-market-report

    What Parameters Are Used to Define the Bone and Mineral Diagnostic Testing Market?

    A bone and mineral diagnostic test is a medical treatment that determines the quantity of calcium and other minerals in a section of bone. This test is used to detect bone loss and osteoporosis, monitor osteoporosis therapy, and assess the risk of fractures.

    Purchase the full report and get a swift delivery:

    https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=10731

    About The Business Research Company:

    With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 3156230293

    Asia +44 2071930708

    Europe +44 2071930708

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • How the Bone and Mineral Diagnostic Testing Market is Positioned for Growth: Trends, Market Size, and Future Opportunities (2025-2034)

    How the Bone and Mineral Diagnostic Testing Market is Positioned for Growth: Trends, Market Size, and Future Opportunities (2025-2034)

    2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!

    What Major Innovations Are Driving the Accelerated Growth of the Bone and Mineral Diagnostic Testing Market?

    The escalation in bone-related ailments is predicted to stimulate the expansion of the bone and mineral diagnostic testing market. These diseases compromise the resilience and suppleness of bones, rendering them susceptible to fractures, and manifest symptoms such as bone discomfort, impaired mobility, and a heightened predisposition to bone fractures. Diagnostic tests for bones and minerals, like bone density exams, can prevent these ailments by detecting lower bone density before escalation into osteoporosis, predicting the likelihood of future fractures, and monitoring the effectiveness of ongoing treatments for osteoporosis. The rise in bone-related diseases, paired with increasing awareness and technological innovation, is predicted to boost the bone and mineral diagnostic testing market. For example, In May 2022, data from The National Center for Biotechnology Information (NCBI), a U.S. government entity, indicated the principal complication of osteoporosis is fractures, with estimates forecasting a 310% hike in worldwide hip fractures among men and a 240% surge among women by 2050. Therefore, the increased occurrence of bone-related diseases will catalyze the growth of the bone and mineral diagnostic testing market.

    Get Your Free Sample Report Now – Explore Exclusive Market Insights:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=10731&type=smp

    #What is the Projected CAGR for the Bone and Mineral Diagnostic Testing Market Size from 2025 to 2034?

    There has been a consistent growth in the bone and mineral diagnostic testing market over the past few years. The market value is anticipated to rise from $1.09 billion in 2024 to $1.14 billion in 2025, reflecting a compound annual growth rate (CAGR) of 4.9%. The historical growth of this market can be linked to multiple factors such as increased demands from an aging population, widespread osteoporosis, awareness and education initiatives, and the clinical requirement for monitoring and fracture risk assessment.

    Expectations are high for substantial expansion in the bone and mineral diagnostic testing market in the coming years. The market is predicted to reach a value of “$1.42 billion in 2029, with a compound annual growth rate (CAGR) of 5.6%. The surge within the forecast period is due to improvements in diagnostic methods, a rising number of cases involving metabolic bone illnesses, an increased emphasis on preventative healthcare, and the incorporation of personalized medicine approaches. Looking ahead, the forecast period is set to be shaped by the introduction of biochemical markers, the use of telemedicine and remote observation, the growth in home-testing kits, partnerships aimed at research and development, and a focus on comprehensive diagnostic panels.

    You can Directly Purchase the Report Here:

    https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=10731

    What Are the Most Significant Market Trends Transforming theBone and Mineral Diagnostic Testing Market?

    Cutting-edge technology is emerging as an essential trend in the bone and mineral diagnostic testing market. Companies operating in this sector are leveraging new technologies to maintain their market competitiveness. In May 2022, an innovative MRI technique was developed by GE HealthCare Technologies Inc., a US-based medical technology company. This new MRI technique uses cutting-edge pulse sequences, such as zero echo time (ZTE), which allows for the visualisation of tendons, ligaments, calcium deposits, and cortical bone structures. The technique, a significant step in MR bone imaging, provides a CT-like image contrast at a 3D isotropic resolution, without exposing the patient to harmful ionizing radiation. Presently, it serves to obtain morphological data on cortical bone structures in anatomical regions like the shoulder, hip, skull, foot/ankle, and spine. Its potential is particularly noteworthy in cases where frequent CT scans are necessary, particularly if low-dose CT options are not available.

    What Are the Top Market Players Propelling the Growth of theBone and Mineral Diagnostic Testing Industry?

    Major companies operating in the bone and mineral diagnostic testing market include Abbott Laboratories, bioMérieux SA, DiaSorin S.p.A., QuidelOrtho Corporation, Siemens Healthineers AG, F. Hoffmann-La Roche AG, GE HealthCare Technologies Inc., Hologic Inc., Beammed Ltd., Swissray International Inc., Osteosys Co. Ltd., Diagnostic Medical System SA, Medonica Co. Ltd., Epitope Diagnostics Inc., Alere Inc., Beckman Coulter Inc., Bio Rad Laboratories Inc., Calbiotech Inc., Roche Diagnostics India Pvt. Ltd., Ortho-Clinical Diagnostics, Enzo Life Sciences lnc., Medtronic plc, Thermo Fisher Scientific lnc., Sysmex Corporation, EKF Diagnostics, Bruker Corporation, Esaote SpA, Hitachi Ltd., Koninklijke Philips N.V., Mindray Medical International Limited, PerkinElmer Inc., Shimadzu Corporation, Toshiba Medical Systems Corporation, Waters Corporation, Danaher Corporation, Merck KGaA

    Order Your Report Now For A Swift Delivery:

    https://www.thebusinessresearchcompany.com/report/bone-and-mineral-diagnostic-testing-global-market-report

    Which Primary Segments of the Bone and Mineral Diagnostic Testing Market Are Driving Growth and Industry Transformations?

    The bone and mineral diagnostic testing market covered in this report is segmented –

    1) By Product: Assays Or Consumables, Instruments

    2) By Test Type: Enzyme-Linked Immunosorbent Assay (ELISA), Clinical Laboratory Improvement Amendments (CLIA), Other Test Types

    3) By Application: Vitamin D Testing, Bone Metabolism

    Subsegments:

    1) By Assays Or Consumables: Bone Turnover Markers Assays, Vitamin D Assays, Calcium And Phosphate Assays, Sample Collection Kits, Reagents And Standards

    2) By Instruments: Bone Densitometers, X-Ray Machines, Ultrasound Devices, MRI Machines, Other Diagnostic Instruments

    Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!

    https://www.thebusinessresearchcompany.com/customise?id=10731&type=smp

    Which Regions Are Key Players in the Growth of the #What Major Innovations Are Driving the Accelerated Growth of the Bone and Mineral Diagnostic Testing Market?# Market?

    North America was the largest region in the bone and mineral diagnostic testing market in 2024. The regions covered in the bone and mineral diagnostic testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

    Browse Through More Reports Similar to the Gobal Bone and Mineral Diagnostic Testing Maret 2025, By The Business Research Company:

    Facial Tissues Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/facial-tissues-global-market-report

    Prosthetic Heart Valve Devices And Equipment Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/prosthetic-heart-valve-devices-and-equipment-global-market-report

    Biotechnology Services Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/biotechnology-services-global-market-report

    About The Business Research Company:

    With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

    Contact us at:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 3156230293

    Asia +44 2071930708

    Europe +44 2071930708

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

    Found this article helpful? Share it on: